MetaCap

Aurora Cannabis (ACB) vs Orchestra BioMed (OBIO)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Orchestra BioMed (OBIO) has outperformed Aurora Cannabis (ACB) over the past year, gaining 45.3% versus a loss of 1.2%. Over five years, OBIO leads with a -33.3% price change compared with -93.9% for ACB. Orchestra BioMed is the larger company by market cap ($517.9 million vs $273.5 million), about 1.9 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ACB-1.19%OBIO+45.25%
+70%+13%-44%
Nov 21, 20251 yearNov 20, 2026
ACB-94.09%OBIO-33.27%
+128%+11%-107%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ACB versus OBIO key metrics
MetricACBOBIO
Share price$4.16$6.58
Market cap$273.50M$517.88M
1-day change-2.35%-6.00%
YTD return-1.42%+58.55%
1-year return-1.19%+45.25%
5-year return-93.87%-33.27%
EPS (TTM)$-0.19$-0.75
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)—$33.48M
Revenue growth (YoY)—+1169.22%
Net income (latest FY)—$-52.70M
Gross margin—99.43%
Operating margin—-154.73%
Net margin—-157.40%
52-week high$6.36$7.83
52-week low$2.56$3.46
Distance from 52-week high-34.59%-15.91%
Analyst consensusunderperformstrong_buy
Avg. price target upside—+101.98%
Average volume1.31M420.19K
Shares outstanding65.74M78.70M
Employees1,02886
SectorHealth CareHealth Care
Industry Medicinal Chemicals and Botanical Products Medicinal Chemicals and Botanical Products

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • OBIO has outperformed ACB by 46.4 percentage points over the past year.

About Aurora Cannabis

ACB stock →

Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis products in Canada and internationally. The company offers pharmaceutical-grade cannabis products; and medical and consumer cannabis products.

Health Care · Medicinal Chemicals and Botanical Products · 1,028 employees

About Orchestra BioMed

OBIO stock →

Orchestra BioMed Holdings, Inc. operates as a biomedical company in the United States.

Health Care · Medicinal Chemicals and Botanical Products · 86 employees

ACB vs OBIO FAQ

Which is bigger, Aurora Cannabis or Orchestra BioMed?

Orchestra BioMed (OBIO) is larger, with a market capitalization of $517.88M compared with $273.50M for Aurora Cannabis (ACB).

Which stock has performed better over the past year, ACB or OBIO?

OBIO returned +45.25% over the past 12 months, compared with -1.19% for ACB (price return, excluding dividends). Past performance does not predict future results.

Are Aurora Cannabis and Orchestra BioMed in the same industry?

Yes. Both are classified in the Medicinal Chemicals and Botanical Products industry within the Health Care sector.

More comparisons